<DOC>
	<DOCNO>NCT02844660</DOCNO>
	<brief_summary>A Multicenter , Prospective , Randomized Controlled Comparative Parallel Study To determine safety effectiveness EpiCord compare standard care ( SOC ) therapy treatment chronic , non-healing diabetic foot ulcer ( DFUs )</brief_summary>
	<brief_title>Dehydrated Human Umbilical Cord Allograft Management Diabetic Foot Ulcers</brief_title>
	<detailed_description>This prospective , multicenter , randomize control trial . The trial include approximately 66 subject 10 experienced clinical center United States . The estimated enrollment period 18 week ( include 2-week run-in period ) . After complete 2-week screening period , subject follow least 16 week post-randomization .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . Subject known history Type 1 Type 2 diabetes ( criterion diagnosis diabetes mellitus per ADA ) . 2 . Index ulcer characteristic : . Ulcer present ≥ 30 day prior randomization ( Day 0 ) b . Index ulcer locate ankle c. Index ulcer area debridement ≥ 1 cm² ≤ 15 cm² randomization visit 3 . Subject complete 14day runin period ≤ 30 % wound area reduction postdebridement . 4 . Subject adequate circulation affect extremity , demonstrate one follow within past 60 day : Dorsum transcutaneous oxygen test ( TcPO2 ) result ≥ 30 mmHg , OR ABIs result ≥ 0.7 ≤ 1.2 , OR Doppler arterial waveform , triphasic biphasic ankle affect foot 5 . Age ≥ 18 6 . The subject willing able provide inform consent participate procedure followup evaluation necessary complete study 1 . Index Ulcer Assessment : 1 . Penetrates totendon , bone 2 . Presence another diabetic foot ulcer within 3 cm index ulcer 3 . Index ulcer determine due active Charcot deformity major structural abnormality foot 4 . Exhibits clinical sign symptom infection 5 . Known suspected local skin malignancy index diabetic ulcer 6 . Wound duration &gt; one year without intermittent closure 2 . Prior therapy Subjects receive treatment follow eligible enrollment : 1 . In last 7 day Negative pressure wound therapy ( wound vac SNaP® ) index ulcer 2 . In last 7 day Hyperbaric oxygen ( HBO ) therapy 3 . In last 10 day Chemical debridement , Dakin 's solution , medical honey therapy 4 . In last 30 day Treatment cytotoxic chemotherapy , application topical steroid ulcer surface , use ≥ 14 day immunesuppressants ( include systemic corticosteroid ) ; , subject anticipate require medication course study 5 . In last 30 day study ulcer treatment biological skin substitute , include EpiCord , biomedical topical growth factor , tissue engineer material ( e.g . Apligraf® Dermagraft® ) , scaffold material ( e.g . OASIS® Wound Matrix , MatriStem® Wound Matrix , Grafix , etc . ) 6 . In last 30 day Subject investigational drug ( ) therapeutic device ( ) 7 . In last 6 month Amputation revascularization ( surgical stenting ) affect leg foot 3 . Subject criterion make subject ineligible enrollment : 1 . Known osteomyelitis active cellulitis wound site 2 . Hemoglobin A1C &gt; 12 last 60 day prior randomization 3 . History Immune system disorder include Systemic Lupus Erythematosus ( SLE ) , Fibromyalgia , Acquired Immunodeficiency Syndrome ( AIDS ) HIV 4 . Allergy known sensitivity Aminoglycosides gentamicin sulfate and/or streptomycin sulfate 5 . Presence condition ( include current drug alcohol abuse , medical psychiatric condition ) likely impair understand compliance study protocol judgment Investigator 6 . Pregnancy enrollment within last 6 month , woman breastfeed , woman childbearing potential planning become pregnant time study OR unwilling/unable use acceptable method contraception ( birth control pill , barrier , abstinence ) 7 . Known history poor compliance medical treatment 8 . Subjects currently enrol study . Concurrent enrollment study prohibit 9 . Subjects currently receive radiation therapy chemotherapy 10 . Patients currently dialysis plan start dialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Foot Diseases</keyword>
	<keyword>Foot Ulcer</keyword>
</DOC>